Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             112 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Addition of interferon-alpha to a standard maturation cocktail induces CD38 up-regulation and increases dendritic cell function Trepiakas, Redas
2009
27 Supplement 6 p. 2213-2219
7 p.
artikel
2 Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990–2007 Niu, Manette T.
2009
27 Supplement 6 p. 290-297
8 p.
artikel
3 A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults Talaat, Kawsar R.
2009
27 Supplement 6 p. 3744-3753
10 p.
artikel
4 A multinational, randomized, placebo-controlled trial to assess the immunogenicity, safety, and tolerability of live attenuated influenza vaccine coadministered with oral poliovirus vaccine in healthy young children Breiman, Robert F.
2009
27 Supplement 6 p. 5472-5479
8 p.
artikel
5 Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: Methodological difficulties and imperfect solutions De Wals, Philippe
2009
27 Supplement 6 p. 3223-3227
5 p.
artikel
6 An E7-based therapeutic vaccine protects mice against HPV16 associated cancer Venuti, Aldo
2009
27 Supplement 6 p. 3395-3397
3 p.
artikel
7 An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague Yamanaka, Hitoki
2009
27 Supplement 6 p. 80-87
8 p.
artikel
8 A novel DNA vaccine containing multiple TB-specific epitopes casted in a natural structure (ECANS) confers protective immunity against pulmonary mycobacterial challenge Gao, Haifeng
2009
27 Supplement 6 p. 5313-5319
7 p.
artikel
9 A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine Ambrozaitis, Arvydas
2009
27 Supplement 6 p. 6022-6029
8 p.
artikel
10 A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials Boge, Thierry
2009
27 Supplement 6 p. 5677-5684
8 p.
artikel
11 A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period Korematsu, Seigo
2009
27 Supplement 6 p. 5041-5042
2 p.
artikel
12 Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus Tiwari, Mugdha
2009
27 Supplement 6 p. 2513-2522
10 p.
artikel
13 Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease Frasch, Carl E.
2009
27 Supplement 6 p. B112-B116
nvt p.
artikel
14 Basal and stimulus-induced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals Liu, Tong
2009
27 Supplement 6 p. 674-683
10 p.
artikel
15 Booster vaccinations against tick-borne encephalitis: 6 Years follow-up indicates long-term protection Paulke-Korinek, Maria
2009
27 Supplement 6 p. 7027-7030
4 p.
artikel
16 Chimeric alphavirus vaccine candidates protect mice from intranasal challenge with western equine encephalitis virus Atasheva, Svetlana
2009
27 Supplement 6 p. 4309-4319
11 p.
artikel
17 Collection of routine national seasonal influenza vaccine coverage data from GP practices in England using a web-based collection system Gates, Peter
2009
27 Supplement 6 p. 6669-6677
9 p.
artikel
18 Considerations regarding efficacy endpoints in HIV vaccine trials: Executive summary and recommendations of an expert consultation jointly organized by WHO, UNAIDS and ANRS in support of the Global HIV Vaccine Enterprise Fruth, Uli
2009
27 Supplement 6 p. 1989-1996
8 p.
artikel
19 Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy Dirix, V.
2009
27 Supplement 6 p. 6042-6047
6 p.
artikel
20 Development of measles vaccines in Japan Ueda, Shigeharu
2009
27 Supplement 6 p. 3230-3231
2 p.
artikel
21 Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status Asturias, Edwin J.
2009
27 Supplement 6 p. 3650-3654
5 p.
artikel
22 Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques Walsh, Stephen R.
2009
27 Supplement 6 p. 4990-5000
11 p.
artikel
23 Economic benefits for the family of inactivated subunit virosomal influenza vaccination of healthy children aged 3–14 years during the annual health examination in private paediatric offices Salleras, L.
2009
27 Supplement 6 p. 3454-3458
5 p.
artikel
24 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
25 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
26 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
27 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
28 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
29 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
30 Editorial Board 2009
27 Supplement 6 p. CO2-
1 p.
artikel
31 Effectiveness of inactivated influenza vaccine in children less than 5 years of age over multiple influenza seasons: A case–control study Joshi, Avni Y.
2009
27 Supplement 6 p. 4457-4461
5 p.
artikel
32 Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence Bonanni, Paolo
2009
27 Supplement 6 p. A46-A53
nvt p.
artikel
33 Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials Rhorer, Janelle
2009
27 Supplement 6 p. 1101-1110
10 p.
artikel
34 Enhanced immunogenicity of an oral inactivated cholera vaccine in infants in Bangladesh obtained by zinc supplementation and by temporary withholding breast-feeding Ahmed, Tanvir
2009
27 Supplement 6 p. 1433-1439
7 p.
artikel
35 Estimating vaccination coverage: Validity of household-retained vaccination cards and parental recall Luman, Elizabeth T.
2009
27 Supplement 6 p. 2534-2539
6 p.
artikel
36 Evaluation of Echinococcus multilocularis tetraspanins as vaccine candidates against primary alveolar echinococcosis Dang, Zhisheng
2009
27 Supplement 6 p. 7339-7345
7 p.
artikel
37 Evaluation of immune responses and protective efficacy in a goat model following immunization with a coctail of recombinant antigens and a polyprotein of Mycobacterium avium subsp. paratuberculosis Kathaperumal, Kumanan
2009
27 Supplement 6 p. 123-135
13 p.
artikel
38 Evaluation of Japanese encephalitis virus DNA vaccine candidates in rhesus monkeys [Macaca mulatta] Bharati, Kaushik
2009
27 Supplement 6 p. 10-16
7 p.
artikel
39 Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus Li, Yaoming
2009
27 Supplement 6 p. 6004-6010
7 p.
artikel
40 Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months King Jr., James C.
2009
27 Supplement 6 p. 6589-6594
6 p.
artikel
41 Extended safety studies of the attenuated live tuberculosis vaccine SO2 based on phoP mutant Cardona, P.J.
2009
27 Supplement 6 p. 2499-2505
7 p.
artikel
42 First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain Ballesteros, C.
2009
27 Supplement 6 p. 6662-6668
7 p.
artikel
43 HLA haplotype and supertype associations with cellular immune responses and cytokine production in healthy children after rubella vaccine Ovsyannikova, Inna G.
2009
27 Supplement 6 p. 3349-3358
10 p.
artikel
44 Household survey of hepatitis B vaccine coverage among Brazilian children Luna, Expedito J.A.
2009
27 Supplement 6 p. 5326-5331
6 p.
artikel
45 Human papillomavirus genotypes and phylogenetic analysis of HPV-16 variants in HIV-1 infected subjects in Italy Tanzi, Elisabetta
2009
27 Supplement 6 p. A17-A23
nvt p.
artikel
46 Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5 Zhou, Mingguang
2009
27 Supplement 6 p. 5271-5277
7 p.
artikel
47 Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination Zinckgraf, John W.
2009
27 Supplement 6 p. 5393-5401
9 p.
artikel
48 IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants Soininen, Anu
2009
27 Supplement 6 p. 2680-2688
9 p.
artikel
49 Immunization of young African green monkeys with OprF epitope 8–OprI–type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa Weimer, Eric T.
2009
27 Supplement 6 p. 6762-6769
8 p.
artikel
50 Immunization with inflammatory proteome of Brugia malayi adult worm induces a Th1/Th2-immune response and confers protection against the filarial infection Sahoo, M.K.
2009
27 Supplement 6 p. 4263-4271
9 p.
artikel
51 Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: A randomized controlled trial Chiu, Susan S.
2009
27 Supplement 6 p. 4834-4839
6 p.
artikel
52 Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months–2 years or 2–6 years primed with measles-mumps-rubella (MMR) vaccine Gillet, Y.
2009
27 Supplement 6 p. 446-453
8 p.
artikel
53 Immunogenicity of candidate chimeric DNA vaccine against tuberculosis and leishmaniasis Dey, Ayan
2009
27 Supplement 6 p. 5152-5160
9 p.
artikel
54 Immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-infected pregnant women and kinetics of passively acquired antibodies in young infants Almeida, Volia De Carvalho
2009
27 Supplement 6 p. 3856-3861
6 p.
artikel
55 Immunological responses to pneumococcal vaccine in frail older people Ridda, I.
2009
27 Supplement 6 p. 1628-1636
9 p.
artikel
56 Immunology of combining CRM197 conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants Lagos, Rosanna
2009
27 Supplement 6 p. 2299-2305
7 p.
artikel
57 Improved immunization practices reduce childhood hepatitis B infection in Tonga Danielsson, Niklas
2009
27 Supplement 6 p. 4462-4467
6 p.
artikel
58 Infection with a low virulent Mycoplasma hyopneumoniae isolate does not protect piglets against subsequent infection with a highly virulent M. hyopneumoniae isolate Villarreal, I.
2009
27 Supplement 6 p. 1875-1879
5 p.
artikel
59 Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy Demento, Stacey L.
2009
27 Supplement 6 p. 3013-3021
9 p.
artikel
60 Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination Ovsyannikova, Inna G.
2009
27 Supplement 6 p. 3359-3366
8 p.
artikel
61 Influenza vaccination in patients with cirrhosis and in liver transplant recipients Gaeta, Giovanni B.
2009
27 Supplement 6 p. 3373-3375
3 p.
artikel
62 Influenza vaccination rates in Ontario children: Implications for universal childhood vaccination policy Moran, Kathy
2009
27 Supplement 6 p. 2350-2355
6 p.
artikel
63 International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19–20 July 2007 Tondella, M.L.
2009
27 Supplement 6 p. 803-814
12 p.
artikel
64 Investigation of serum bactericidal activity in childhood and adolescence 3–6 years after vaccination with a single dose of serogroup C meningococcal conjugate vaccine Sakou, Irine-Ikbale
2009
27 Supplement 6 p. 4408-4411
4 p.
artikel
65 Kinetics of antibody responses after primary immunization with meningococcal serogroup C conjugate vaccine or secondary immunization with either conjugate or polysaccharide vaccine in adults de Voer, Richarda M.
2009
27 Supplement 6 p. 6974-6982
9 p.
artikel
66 Kinetics of viral shedding and immune responses in adults following administration of cold-adapted influenza vaccine Hammitt, Laura L.
2009
27 Supplement 6 p. 7359-7366
8 p.
artikel
67 Liposome-encapsulated HIV-1 Gag p24 containing lipid A induces effector CD4+ T-cells, memory CD8+ T-cells, and pro-inflammatory cytokines Steers, Nicholas J.
2009
27 Supplement 6 p. 6939-6949
11 p.
artikel
68 Live vaccination with an H5-hemagglutinin-expressing infectious laryngotracheitis virus recombinant protects chickens against different highly pathogenic avian influenza viruses of the H5 subtype Pavlova, Sophia P.
2009
27 Supplement 6 p. 5085-5090
6 p.
artikel
69 Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine Rowhani-Rahbar, Ali
2009
27 Supplement 6 p. 5612-5619
8 p.
artikel
70 Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus Zuccotti, Gian Vincenzo
2009
27 Supplement 6 p. 5357-5362
6 p.
artikel
71 Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan Kao, Jung-Ta
2009
27 Supplement 6 p. 1858-1862
5 p.
artikel
72 MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination Vesikari, T.
2009
27 Supplement 6 p. 6291-6295
5 p.
artikel
73 Neonatal pneumococcal conjugate vaccine immunization primes T cells for preferential Th2 cytokine expression: A randomized controlled trial in Papua New Guinea van den Biggelaar, Anita. H.J.
2009
27 Supplement 6 p. 1340-1347
8 p.
artikel
74 Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper Arce-Estrada, Viviana
2009
27 Supplement 6 p. 460-466
7 p.
artikel
75 Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine Henderson, Heather
2009
27 Supplement 6 p. 7194-7197
4 p.
artikel
76 Pathobiology of triple reassortant H3N2 influenza viruses in breeder turkeys and its potential implication for vaccine studies in turkeys Pillai, S.P.S.
2009
27 Supplement 6 p. 819-824
6 p.
artikel
77 Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children Simell, Birgit
2009
27 Supplement 6 p. 4615-4621
7 p.
artikel
78 Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia Wood, James G.
2009
27 Supplement 6 p. 313-318
6 p.
artikel
79 Predictive value of seizure ICD-9 codes for vaccine safety research Shui, Irene M.
2009
27 Supplement 6 p. 5307-5312
6 p.
artikel
80 Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus Biesova, Zuzana
2009
27 Supplement 6 p. 6234-6238
5 p.
artikel
81 Preparing for HPV vaccination in South Africa: Key challenges and opinions Harries, Jane
2009
27 Supplement 6 p. 38-44
7 p.
artikel
82 Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan Children, in the context of vaccine vector efficacy Dudareva, M.
2009
27 Supplement 6 p. 3501-3504
4 p.
artikel
83 Prevention of otitis media: Now a reality? Schuerman, Lode
2009
27 Supplement 6 p. 5748-5754
7 p.
artikel
84 Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-γ producing T-cells Badell, Edgar
2009
27 Supplement 6 p. 28-37
10 p.
artikel
85 Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines Franka, Richard
2009
27 Supplement 6 p. 7149-7155
7 p.
artikel
86 Reactogenicity and tolerability of a non-adjuvanted 11-valent diphtheria-tetanus toxoid pneumococcal conjugate vaccine in Filipino children Ugpo, Juanita
2009
27 Supplement 6 p. 2723-2729
7 p.
artikel
87 Recombinant interferon-α2b improves immune response to hepatitis B vaccination in haemodialysis patients: Results of a randomised clinical trial Miquilena-Colina, María E.
2009
27 Supplement 6 p. 5654-5660
7 p.
artikel
88 Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses Schroeder, Juliane
2009
27 Supplement 6 p. 6748-6754
7 p.
artikel
89 RepliVAX WN, a single-cycle flavivirus vaccine to prevent West Nile disease, elicits durable protective immunity in hamsters Widman, Douglas G.
2009
27 Supplement 6 p. 5550-5553
4 p.
artikel
90 Safe vaccination of children with a virosomal adjuvanted influenza vaccine Künzi, Valérie
2009
27 Supplement 6 p. 1261-1265
5 p.
artikel
91 Scheduling of measles vaccination in low-income countries: Projections of a dynamic model Bauch, C.T.
2009
27 Supplement 6 p. 4090-4098
9 p.
artikel
92 Schistosoma mansoni ex vivo lung-stage larvae excretory–secretory antigens as vaccine candidates against schistosomiasis Ridi, Rashika El
2009
27 Supplement 6 p. 666-673
8 p.
artikel
93 Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6–23 months of age Rosenberg, Melissa
2009
27 Supplement 6 p. 4278-4283
6 p.
artikel
94 Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep Oura, C.A.L.
2009
27 Supplement 6 p. 7326-7330
5 p.
artikel
95 Seroprevalence of bactericidal antibody against Neisseria meningitidis serogroup C in pre-vaccinal era: The Italian epidemiological scenario Gasparini, R.
2009
27 Supplement 6 p. 3435-3438
4 p.
artikel
96 Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia Pathirana, D.
2009
27 Supplement 6 p. 4551-4559
9 p.
artikel
97 Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults Schwarz, Tino F.
2009
27 Supplement 6 p. 6284-6290
7 p.
artikel
98 Surveillance of rotavirus in a rural diarrhoea treatment centre in Bangladesh, 2000–2006 Zaman, K.
2009
27 Supplement 6 p. F31-F34
nvt p.
artikel
99 Susceptibility of the Aotus nancymaae owl monkey to eastern equine encephalitis Espinosa, Benjamin J.
2009
27 Supplement 6 p. 1729-1734
6 p.
artikel
100 T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune® Araújo, Márcio Sobreira Silva
2009
27 Supplement 6 p. 1008-1017
10 p.
artikel
101 The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep Haçarız, O.
2009
27 Supplement 6 p. 45-50
6 p.
artikel
102 The first clinical use of a live-attenuated Listeria monocytogenes vaccine: A Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervix Maciag, Paulo Cesar
2009
27 Supplement 6 p. 3975-3983
9 p.
artikel
103 The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap Heldens, J.G.M.
2009
27 Supplement 6 p. 5530-5537
8 p.
artikel
104 The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice Kovacs-Nolan, J.
2009
27 Supplement 6 p. 2055-2064
10 p.
artikel
105 The novel adjuvant CoVaccineHT™ increases the immunogenicity of cell-culture derived influenza A/H5N1 vaccine and induces the maturation of murine and human dendritic cells in vitro Bodewes, R.
2009
27 Supplement 6 p. 6833-6839
7 p.
artikel
106 Therapeutic vaccine IC41 as late add-on to standard treatment in patients with chronic hepatitis C Wedemeyer, Heiner
2009
27 Supplement 6 p. 5142-5151
10 p.
artikel
107 Toxoplasma gondii microneme protein 6 (MIC6) is a potential vaccine candidate against toxoplasmosis in mice Peng, Gao-Hui
2009
27 Supplement 6 p. 6570-6574
5 p.
artikel
108 Universal childhood immunisation against Streptococcus pneumoniae: The five-year experience of Liguria Region, Italy Durando, Paolo
2009
27 Supplement 6 p. 3459-3462
4 p.
artikel
109 Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey Duchet-Niedziolka, P.
2009
27 Supplement 6 p. 1523-1529
7 p.
artikel
110 Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro Agrawal, Sudhanshu
2009
27 Supplement 6 p. 88-92
5 p.
artikel
111 Vaxfectin®-adjuvanted seasonal influenza protein vaccine: Correlation of systemic and local immunological markers with formulation parameters Shlapobersky, Mark
2009
27 Supplement 6 p. 6404-6410
7 p.
artikel
112 Willingness of healthcare workers to accept voluntary stockpiled H5N1 vaccine in advance of pandemic activity Pareek, Manish
2009
27 Supplement 6 p. 1242-1247
6 p.
artikel
                             112 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland